Qiagen NV QGEN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
49.92UNCH (UNCH)
Volume
4,250
Close
49.92quote price arrow up+0.14 (+0.28%)
Volume
298,072
52 week range
41.32 - 58.00
Loading...
  • Open49.56
  • Day High49.92
  • Day Low49.42
  • Prev Close49.78
  • 52 Week High58.00
  • 52 Week High Date11/26/21
  • 52 Week Low41.32
  • 52 Week Low Date03/08/22

Key Stats

  • Market Cap11.366B
  • Shares Out227.68M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.30
  • YTD % Change-10.18

KEY STATS

  • Open49.56
  • Day High49.92
  • Day Low49.42
  • Prev Close49.78
  • 52 Week High58.00
  • 52 Week High Date11/26/21
  • 52 Week Low41.32
  • 52 Week Low Date03/08/22
  • Market Cap11.366B
  • Shares Out227.68M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.30
  • YTD % Change-10.18

RATIOS/PROFITABILITY

  • EPS (TTM)2.23
  • P/E (TTM)22.42
  • Fwd P/E (NTM)26.36
  • EBITDA (TTM)864.751M
  • ROE (TTM)16.43%
  • Revenue (TTM)2.261B
  • Gross Margin (TTM)64.44%
  • Net Margin (TTM)22.75%
  • Debt To Equity (MRQ)58.97%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date01/25/2017
  • Div Amount1.08
  • Split Date-
  • Split Factor-

Latest On Qiagen NV

There is no recent news for this security.

Profile

MORE
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other...
Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Address
Hulsterweg 82
Venlo
5912 PL
Netherlands